Heparin-bonded circuits versus nonheparin-bonded circuits: an evaluation of their effect on clinical outcomes.
about
Retrospective analysis of outcome data with regards to the use of Phisio®-, Bioline®- or Softline®-coated cardiopulmonary bypass circuits in cardiac surgery.The artificial endotheliumAn ex vivo evaluation of blood coagulation and thromboresistance of two extracorporeal circuit coatings with reduced and full heparin dose.Is a fully heparin-bonded cardiopulmonary bypass circuit superior to a standard cardiopulmonary bypass circuit?Effects of cardiopulmonary bypass on lung nuclear factor-kappa B activity, cytokine release, and pulmonary function in dogsExtracorporeal membrane oxygenation circuitry.Statin prophylaxis and inflammatory mediators following cardiopulmonary bypass: a systematic reviewImmunologic and Infectious Diseases in Pediatric Cardiac Critical Care: Proceedings of the 10th International Pediatric Cardiac Intensive Care Society Conference.Coronary artery rupture in blunt thoracic trauma: a case report and review of literature.A prospective randomized trial comparing the clinical effectiveness and biocompatibility of heparin-coated circuits and PMEA-coated circuits in pediatric cardiopulmonary bypass.Bioengineering of improved biomaterials coatings for extracorporeal circulation requires extended observation of blood-biomaterial interaction under flow.The effect of a cardiopulmonary bypass system with biocompatible coating on fibrinogen levels determined by the TEG--functional fibrinogen method: preliminary results.When Blood Is Touched.Institutional variability of intraoperative red blood cell utilization in coronary artery bypass graft surgery.Wet-priming extracorporeal membrane oxygenation device maintains sterility for up to 35 days of follow-up.VV extracorporeal life support for the Third Millennium: will we need anticoagulation?Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgery
P2860
Q34366543-582DBC8A-40C5-4120-83CB-AEA4D09637CEQ34852479-DC5AF060-2DBD-429B-B5EF-1206816AB15AQ35121463-FC9E04D1-000B-45D1-9E3D-A1EA0A7DC404Q35845114-35FEB883-F7E5-460F-92E4-E288C0059D28Q36553132-EF9CCCDB-62A1-4FFC-B937-94CABB3B4570Q37092224-FEE17DAB-6052-4707-B7B2-4F860D71581EQ37443179-371DA58F-87F6-415B-92AD-3B0E7EF91304Q38607397-4711FE77-24D2-4AC7-8A0B-1000D69DE6B5Q38916268-324D35BF-FB15-41AB-808A-01D3C86B4AC0Q40675871-564BC9DA-8B05-4795-B8D4-0C1A4A103174Q43049625-52CDD7B5-CD40-4A0B-82D4-0B03000380BBQ44562744-5F9E201B-B42A-44A7-93D6-AD063BEA95EBQ47116617-66FE27AA-441A-452C-996C-DA27477A2DCEQ50602721-9137D60D-AB2B-47C2-9625-FB8EE5C4F642Q54321563-98F995B6-498D-4FE7-8628-55314A16B66BQ55349297-55050A33-9F93-4C30-B625-30BDBFBF2A72Q56031831-7A6F0C0A-4790-403A-A58D-946F2C0B2AD3
P2860
Heparin-bonded circuits versus nonheparin-bonded circuits: an evaluation of their effect on clinical outcomes.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Heparin-bonded circuits versus ...... r effect on clinical outcomes.
@ast
Heparin-bonded circuits versus ...... r effect on clinical outcomes.
@en
type
label
Heparin-bonded circuits versus ...... r effect on clinical outcomes.
@ast
Heparin-bonded circuits versus ...... r effect on clinical outcomes.
@en
prefLabel
Heparin-bonded circuits versus ...... r effect on clinical outcomes.
@ast
Heparin-bonded circuits versus ...... r effect on clinical outcomes.
@en
P2093
P1476
Heparin-bonded circuits versus ...... r effect on clinical outcomes.
@en
P2093
Fabio Bartolozzi
James Kinross
Martin Hayward
Omar Mangoush
Saleem Haj-Yahia
Sanjay Purkayastha
P304
P356
10.1016/J.EJCTS.2007.01.029
P577
2007-02-15T00:00:00Z